Bioconjugate Chemistry · 2018 · 40 citations · 38 references
PharmacyOncologyPharmacologyCancer PharmacologyDrug DeliveryTargeted Drug DeliveryCell-penetrating PeptidesPeptide Bond ChemistryPeptide DeliveryPeptide Drug DiscoveryBiocompatibility AssessmentBiocompatibility TestingBiomaterial BiocompatibilityCell Viability AssaysCytotoxicity AssaysMaldi-tof Mass SpectrometryTherapeutic PeptidesTumor-targeting Peptides
Melittin (MLT), as a natural active biomolecule, can penetrate the tumor cell membrane to play a role in cancer treatment and will attract more attention in future development of antitumor drugs. The main component of natural bee venom MLT was modified by introducing a pH-sensitive amide bond between the 2,3-dimethyl maleimide (DMMA) and the lysine (Lys) of MLT (MLT-DMMA). MLT and its corresponding modified peptide MLT-DMMA were used for antitumor and biocompatibility validation. The biomaterial characteristics were tested by MALDI-TOF MS, 1H NMR, IUPAC and HPLC, cell viability, hemolytic and animal experiment safety evaluation. Compared with the primary melittin, the modified peptide showed decreased surface charge and low cytotoxicity in physiological conditions. Moreover, cell assays confirmed the acid-activated conversion of amide bond resulting in adequate safety during delivery and timely antitumor activity in tumor lesions. Thus, MLT-DMMA provided a feasible platform to improve the targeted and safe antitumor applications.
38
Acid-Active Cell-Penetrating Peptides for in Vivo Tumor-Targeted Drug Delivery
Erlei Jin, Bo Zhang, Xuanrong Sun et al. · Journal of the American Chemical Society · 2012 · 329 citations
Protein Encapsulation via Polypeptide Complex Coacervation
Katie A. Black, Dimitrios Priftis, Sarah L. Perry et al. · ACS Macro Letters · 2014 · 320 citations